Works matching IS 21522650 AND DT 2025 AND VI 25 AND IP 12

Results: 17

SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 13, doi. 10.1016/j.clml.2024.08.005

By:

Iacobucci, Ilaria;
Papayannidis, Cristina

Publication type:

Article

SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 1, doi. 10.1016/j.clml.2024.06.005

By:

Chifotides, Helen T.;
Bose, Prithviraj

Publication type:

Article

Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e62, doi. 10.1016/j.clml.2024.07.015

By:

Dahl Hamnvik, Lars Henrik;
Eide-Olsen, Stella;
Fosseng, Arne;
Schjesvold, Fredrik Hellem

Publication type:

Article

Efficacy and Safety of the First-in-Class STAMP-Inhibitor Asciminib in Patients With Chronic Myeloid Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e57, doi. 10.1016/j.clml.2024.10.010

By:

Hiroshi Ureshino;
Shinya Kimura

Publication type:

Article

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e50, doi. 10.1016/j.clml.2024.08.006

By:

Aleem, Aamer;
Shaheen, Naila A.;
Algahtani, Farjah;
Jamal, Ahmed;
Alkhudair, Nora;
Alghafis, Mashail;
Iqbal, Zafar;
Zuki Siti, Hajar Wan;
Thomas, Abin;
Alahmari, Bader;
Salama, Hind;
Gmati, Giamal;
Alzahrani, Mohsen;
Alhejazi, Ayman;
Alfayez, Mansour;
Alrajhi, Abdullah;
Marei, Mohammed A.;
Alaskar, Ahmed

Publication type:

Article

Dementia Incidence in Survivors of Multiple Myeloma: A National Case-Control Study Conducted in Korea (The CAREMM-2106 Study).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e40, doi. 10.1016/j.clml.2024.08.001

By:

Jeonghoon Ha;
Suein Choi;
Seulji Moon;
Jinseon Han;
Jeongyoon Lee;
Sung-Soo Park;
Sheng-Min Wang;
Seunghoon Han;
Chang-Ki Min

Publication type:

Article

Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e34, doi. 10.1016/j.clml.2024.08.009

By:

Breccia, Massimo;
Cucci, Rosalba;
Marsili, Giovanni;
Castagnetti, Fausto;
Galimberti, Sara;
Izzo, Barbara;
SorÃ , Federica;
Soverini, Simona;
Messina, Monica;
Piciocchi, Alfonso;
Bonifacio, Massimiliano;
Cilloni, Daniela;
Iurlo, Alessandra;
Martinelli, Giovanni;
Rosti, Gianantonio;
Stagno, Fabio;
Fazi, Paola;
Vignetti, Marco;
Pane, Fabrizio

Publication type:

Article

DA-R-EPOCH May Mitigate the Adverse Prognostic Implication of the Diagnosis-to-Treatment Interval (DTI) in Large B-Cell Lymphomas.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e26, doi. 10.1016/j.clml.2024.09.012

By:

Allen, Jessica;
Abbott, Diana;
Eskandar, Joy;
Bair, Steven M.;
Haverkos, Bradley;
Jasem, Jagar;
Kamdar, Manali;
Major, Ajay

Publication type:

Article

Comparison of Long-Term Outcomes of Double Unit Cord Blood Versus Haploidentical Donor Transplantation in Adult Patients With Acute Lymphoblastic Leukemia Regarding KIR-Ligand Mismatch.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e11, doi. 10.1016/j.clml.2024.11.004

By:

Seonghan Lee;
Jae-Ho Yoon;
Daehun Kwag;
Gi-June Min;
Sung-Soo Park;
Park, Silvia;
Sung-Eun Lee;
Byung-Sik Cho;
Ki-Seong Eom;
Yoo-Jin Kim;
Hee-Je Kim;
Chang-Ki Min;
Seok-Goo Cho;
Seok Lee

Publication type:

Article

Clinical Characteristics and Survival Outcomes of Patients With Primary and Secondary Plasma Cell Leukemia According to the 2021 Definition: A Single Center Retrospective Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 67, doi. 10.1016/j.clml.2024.10.014

By:

Shalaby, Khalid;
Azad, Farhan;
Parker, Sarah;
Chong Wang;
Han Yu;
Attwood, Kristopher;
Hillengass, Jens

Publication type:

Article

Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect® MM Registry.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 58, doi. 10.1016/j.clml.2024.11.001

By:

Terebelo, Howard R.;
Omel, James;
Wagner, Lynne I.;
Hardin, James W.;
Rifkin, Robert M.;
Ailawadhi, Sikander;
Durie, Brian G. M.;
Narang, Mohit;
Toomey, Kathleen;
Gasparetto, Cristina J.;
Joshi, Prashant;
Yu, Edward;
Flick, E. Dawn;
Ying-Ming Jou;
Lee, Hans C.;
Abonour, Rafat;
Jagannath, Sundar

Publication type:

Article

CD10-Positive Lymphoplasmacytic Lymphoma: A Diagnostic Pitfall.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 23, doi. 10.1016/j.clml.2024.09.004

By:

Yaping Ju;
Stuart, Sophie;
Yue Zhao;
Yi Xie;
Carrillo, Luis F.;
Siddiqi, Imran;
Ling Zhang;
Endi Wang

Publication type:

Article

Brazilian Real-Life Experience of Multiple Myeloma (MMyBRAve): Improvement in Outcomes, But Remaining Diagnostic and Therapeutic Gaps.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 26, doi. 10.1016/j.clml.2024.10.002

By:

Hungria, Vania;
Bittencourt, Rosane Isabel;
Martinez, Gracia Aparecida;
de Andrade Santos, Juliana;
de Almeida, Denise Ramos;
de Piratininga Figueiredo, Vera Lucia;
Cordeiro de Farias, Danielle Leão;
Zanella, Karla Richter;
Muniz, Larissa Barchi;
Senra, Juliana Tosta;
Martins Abreu, Rodrigo;
Mattos, Éderson Roberto

Publication type:

Article

BCMA-Directed MRD Detection as a Predictor of Relapse after BCMA CAR T in Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 52, doi. 10.1016/j.clml.2024.10.003

By:

Rashid, Aliya;
Wesson, William;
Abdallah, Al-Ola;
Snyder, Jordan;
Venkatesh, Priyanka;
Mushtaq, Muhammad U.;
Shune, Leyla;
Witek, Malgorzata A.;
McGuirk, Joseph P.;
Soper, Steven A.;
Wei Cui;
Ahmed, Nausheen

Publication type:

Article

A Real-World Analysis on Access to Triplet and Quadruplet Therapy in Newly Diagnosed Multiple Myeloma Patients in the United States.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e1, doi. 10.1016/j.clml.2024.10.006

By:

Saba, Ludovic;
Chieh-Lin Fu;
Hong Liang;
Chaulagain, Chakra P.

Publication type:

Article

Analysis of Histologic, Immunohistochemical and Genomic Features of Large B Cell Lymphoma Tumors May Predict Response to Polatuzumab Vedotin Based Therapy in Patients With Relapsed/Refractory Disease.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 45, doi. 10.1016/j.clml.2024.08.010

By:

Schneider, Michael;
Nasta, Sunita D.;
Barta, Stefan K.;
Chong, Elise A.;
Svoboda, Jakub;
Schuster, Stephen J.;
Landsburg, Daniel J.

Publication type:

Article

Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 32, doi. 10.1016/j.clml.2024.09.008

By:

Almeida Costa, Bruno;
Alexandre Costa, Thomaz;
Lima Chagas, Gabriel Cavalcante;
Mouhieddine, Tarek H.;
Richter, Joshua;
Usmani, Saad Z.;
Mailankody, Sham;
Rajeeve, Sridevi;
Hashmi, Hamza

Publication type:

Article